Showing results (191-200 of 212) with videos related to
Sort By:
Pageof 22
Molecular Cell|February 18, 2022
HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemiaHuacheng Luo, Ganqian Zhu, Melanie A Eshelman, et al.Endocrinology|June 23, 2017
Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened OsteoanabolismYu Shao, Selene Hernandez-Buquer, Paul Childress, et al.EMBO Reports|August 31, 2023
Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clippingHui Yang, Pinpin Sui, Ying Guo, et al.Science Advances|January 25, 2017
ASXL1 interacts with the cohesin complex to maintain chromatid separation and gene expression for normal hematopoiesisZhaomin Li, Peng Zhang, Aimin Yan, et al.Molecular Endocrinology (Baltimore, Md.)|August 6, 2015
Genome-Wide Mapping and Interrogation of the Nmp4 Antianabolic Bone AxisPaul Childress, Keith R Stayrook, Marta B Alvarez, et al.Nature Communications|March 30, 2021
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemiaGanqian Zhu, Huacheng Luo, Yang Feng, et al.Leukemia|March 21, 2018
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignanciesDaichi Inoue, Takeshi Fujino, Paul Sheridan, et al.Journal of Pediatric Orthopedics|March 14, 2013
Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities ConsortiumDavid A Stevenson, David Little, Linlea Armstrong, et al.Blood|November 9, 2017
Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignanciesHui Yang, Stefan Kurtenbach, Ying Guo, et al.Plos One|June 14, 2018
Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2, Robert Allaway, Steve P Angus, et al.Pageof 22